Structural and dynamic insights into the biased signaling mechanism of the human kappa opioid receptor.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41152269.
- Also identified by DOI 10.1038/s41467-025-64882-1 and PMC identifier 12569041.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The κ-opioid receptor (KOR) is a member of the G protein-coupled receptor (GPCR) family, modulating cellular responses through transducers such as G proteins and β-arrestins. G-protein-biased KOR agonists aim to retain analgesic and antipruritic actions while limiting aversion and sedation. Aiming to inform G-biased KOR agonist design, we analyze signaling-relevant residues from structural and dynamic views. Here we show, using multiple complementary methods, shared residues that determine β-arrestin recruitment by nalfurafine and U-50,488H. Cryo-electron microscopy structures of the KOR-G<sub>i</sub> signaling complexes identify the ligand binding mode in the activated state. Vibrational spectroscopy reveals ligand-induced conformational changes. Cell-based mutant experiments pinpoint four amino acids (K227<sup>5.40</sup>, C286<sup>6.47</sup>, H291<sup>6.52</sup>, and Y312<sup>7.34</sup>; Ballesteros-Weinstein numbering is shown in superscript) that play crucial roles in β-arrestin recruitment. Furthermore, MD simulations revealed that the four mutants tend to adopt conformations with reduced β-arrestin recruitment activity. Our research findings provide a foundation for enhancing KOR-mediated therapeutic effects while minimizing unwanted side effects by targeting specific residues within the KOR ligand-binding pocket, including K227<sup>5.40</sup> and Y312<sup>7.34</sup>, which have previously been implicated in biased signaling.
Medical subject headings
- Analgesics, Non-Narcotic
- Antipruritics
- beta-Arrestins
- Receptors, Opioid, kappa